• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

组织型纤溶酶原激活剂在大鼠实验性血栓上的定位

Localization of tissue plasminogen activator on experimental thrombi in rats.

作者信息

Kimata H, Nakajima K, Koide T, Yamamoto S, Kondo S

机构信息

Tokyo Research Laboratories Kowa Co., Ltd., Japan.

出版信息

J Pharmacobiodyn. 1990 Dec;13(12):751-9. doi: 10.1248/bpb1978.13.751.

DOI:10.1248/bpb1978.13.751
PMID:2129128
Abstract

The localization of tissue plasminogen activator (t-PA) or urokinase plasminogen activator (u-PA) on thrombi was investigated in disseminated intravascular coagulation rats (DIC rats) induced by thrombin. One hour after the intravenous infusion of thrombin to rats, the plasma fibrinogen level decreased, while the plasminogen activator activity in the plasma euglobulin fraction increased. The whole body autoradiography was studied after an injection of [125I]fibrinogen in DIC rats. The high radioactivity which indicated the presence of microthrombi was observed in the renal cortex, liver, spleen and lung. Furthermore, a large venous thrombus with higher radioactivity was observed in the abdominal vena cava. These results show that the thrombin-treated animal is one of the best DIC models. After the intravenous administration of [125I]t-PA, the autoradiograms of DIC rats showed a radioactivity in the blood and much higher radioactivities in the renal cortex, spleen and lung in comparison with the normal rat. However, there was no difference in the distribution of [125I]u-PA between normal and DIC rats at all. The strong radioactivity of [125I]t-PA but not [125I]u-PA was observed on the surface of large thrombus in the vena cava. These results suggest that t-PA localizes more preferentially on microthrombi than u-PA. The ratio of the radioactivity in the tissue to that in the blood was calculated to compare quantitatively the localization of [125I]t-PA and [125I]u-PA on microthrombi formed in organs.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

在由凝血酶诱导的弥散性血管内凝血大鼠(DIC大鼠)中,研究了组织型纤溶酶原激活剂(t-PA)或尿激酶型纤溶酶原激活剂(u-PA)在血栓上的定位。给大鼠静脉输注凝血酶1小时后,血浆纤维蛋白原水平下降,而血浆优球蛋白组分中的纤溶酶原激活剂活性增加。在DIC大鼠注射[125I]纤维蛋白原后进行全身放射自显影研究。在肾皮质、肝脏、脾脏和肺中观察到表明存在微血栓的高放射性。此外,在腹静脉中观察到一个放射性更高的大静脉血栓。这些结果表明,经凝血酶处理的动物是最佳的DIC模型之一。静脉注射[125I]t-PA后,DIC大鼠的放射自显影片显示血液中有放射性,与正常大鼠相比,肾皮质、脾脏和肺中的放射性要高得多。然而,正常大鼠和DIC大鼠之间[125I]u-PA的分布完全没有差异。在腔静脉的大血栓表面观察到[125I]t-PA有强烈放射性,而[125I]u-PA没有。这些结果表明,与u-PA相比,t-PA更优先定位于微血栓上。计算组织与血液中放射性的比值,以定量比较[125I]t-PA和[125I]u-PA在器官中形成的微血栓上的定位。(摘要截短于250字)

相似文献

1
Localization of tissue plasminogen activator on experimental thrombi in rats.组织型纤溶酶原激活剂在大鼠实验性血栓上的定位
J Pharmacobiodyn. 1990 Dec;13(12):751-9. doi: 10.1248/bpb1978.13.751.
2
Localization of tissue plasminogen activator on experimental microthrombi in rats. Microautoradiographic observations.组织型纤溶酶原激活物在大鼠实验性微血栓上的定位。显微放射自显影观察。
J Pharmacobiodyn. 1991 Jan;14(1):25-33. doi: 10.1248/bpb1978.14.25.
3
The tissue plasminogen activator and urokinase response in vivo during natural resolution of venous thrombus.
J Vasc Surg. 1995 Nov;22(5):573-9. doi: 10.1016/s0741-5214(95)70041-2.
4
Comparative thrombolytic properties of tissue-type plasminogen activator (t-PA), single-chain urokinase-type plasminogen activator (u-PA) and K1K2Pu (a t-PA/u-PA chimera) in a combined arterial and venous thrombosis model in the dog.在犬动静脉联合血栓形成模型中组织型纤溶酶原激活剂(t-PA)、单链尿激酶型纤溶酶原激活剂(u-PA)和K1K2Pu(一种t-PA/u-PA嵌合体)的溶栓特性比较
J Am Coll Cardiol. 1992 May;19(6):1350-9. doi: 10.1016/0735-1097(92)90344-m.
5
Binding of human tissue plasminogen activator (t-PA) to blood clots and clot-lytic activity of clot-bound t-PA.人组织型纤溶酶原激活剂(t-PA)与血凝块的结合及血凝块结合型t-PA的溶栓活性。
J Pharmacobiodyn. 1990 Dec;13(12):745-50. doi: 10.1248/bpb1978.13.745.
6
Bolus dose response characteristics of single chain urokinase plasminogen activator and tissue plasminogen activator in a dog model of arterial thrombosis.单链尿激酶型纤溶酶原激活剂和组织型纤溶酶原激活剂在犬动脉血栓形成模型中的推注剂量反应特征。
Thromb Res. 1988 Nov 15;52(4):295-312. doi: 10.1016/0049-3848(88)90071-0.
7
Inactivation of single-chain urokinase-type plasminogen activator by thrombin in human subjects.
J Lab Clin Med. 1999 Aug;134(2):161-7. doi: 10.1016/s0022-2143(99)90121-x.
8
Thrombolytic effect of tissue plasminogen activator in a cerebral embolic model.组织型纤溶酶原激活剂在脑栓塞模型中的溶栓作用。
J Pharmacobiodyn. 1991 Jul;14(7):399-406. doi: 10.1248/bpb1978.14.399.
9
The role of the low-density lipoprotein receptor-related protein (LRP) in the plasma clearance and liver uptake of recombinant single-chain urokinase-type plasminogen activator in rats.低密度脂蛋白受体相关蛋白(LRP)在大鼠体内重组单链尿激酶型纤溶酶原激活剂的血浆清除及肝脏摄取中的作用
Thromb Haemost. 1997 Apr;77(4):710-7.
10
Thrombolysis with human extrinsic (tissue-type) plasminogen activator in rabbits with experimental jugular vein thrombosis. Effect of molecular form and dose of activator, age of the thrombus, and route of administration.用人外源性(组织型)纤溶酶原激活剂对实验性颈静脉血栓形成的家兔进行溶栓治疗。激活剂分子形式和剂量、血栓形成时间以及给药途径的影响
J Clin Invest. 1983 Feb;71(2):368-76. doi: 10.1172/jci110778.